Umoja Biopharma is a startup based in the United States, 1 tracked investor.
Umoja Biopharma is a company headquartered in the United States. Brouky records 1 investor associated with the company.
Umoja Biopharma develops in vivo CAR T cell therapies for cancer treatment using its proprietary VivoVec platform that generates CAR T cells directly in patients, aiming to simplify and accelerate therapy delivery.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.